Public Company

Exscientia

Inventors of the World's first AI designed drugs to enter clinical trials

About

Finding faster and smarter ways to discover new and better drugs is what drives Exscientia. By actively applying AI to precision engineer medicines more rapidly and efficiently, we will enable people to live more healthy and productive lives.

Overview

Founded 2012
Type Public
Longevity related Yes
Location Oxford, Oxfordshire, England, UK

Latest News

Stock

EXAI

Join the Insiders Club.

Plain English. Every week. Free.